How much is SpyGlass Pharma worth in 2026?

SpyGlass Pharma has a current valuation of $355.0M based on their Later Stage VC round and secondary market data.

How much funding has SpyGlass Pharma raised?

SpyGlass Pharma has raised $198.5M in total funding across 2 funding rounds.

SpyGlass Pharma

Surgical DevicesWebsite

SpyGlass Pharma valuation and funding history | Last updated: June 2, 2025 | 2 funding rounds

Current Valuation

$355.0M

As of June 2, 2025

Total Funding Raised

$198.5M

Across 2 rounds

Last Round

Later Stage VC

$75.0M

Last Funding

Jun 2025

Funding date

Capital Efficiency

1.79x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
June 1, 2025	Later Stage VC (Series D)	$75.0M	N/A	-
July 10, 2023	Later Stage VC (Series C)	$90.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

SpyGlass Pharma is currently valued at $355.0M as of June 2, 2025. The company has raised a total of $198.5M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 1.79x, SpyGlass Pharma has achieved a valuation that is 1.79 times the total capital raised.

Track SpyGlass Pharma Valuation Updates

Get notified when SpyGlass Pharma raises new funding or valuation changes

Explore More Data

Detailed analysis for SpyGlass Pharma

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock SpyGlass Pharma's valuation history, funding rounds, and growth metrics.

No credit card required

What is SpyGlass Pharma Worth in 2026?

SpyGlass Pharma is a leading private company in the Surgical Devices sector. Track SpyGlass Pharma's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How SpyGlass Pharma Valuation is Determined

Private company valuations like SpyGlass Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.